|
(3aR,8aS)-2-([2,2'-Bipyridin]-6-yl)-8,8a-dihydro-3aH-indeno[1,2-d]oxazole
|
|
2094476-56-7
|
|
(3aR,8aS)-2-(6-Benzhydrylpyridin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole
|
|
2757082-63-4
|
|
(3aR,8aS)-2-(6-Phenylpyridin-2-yl)-8,8a-dihydro-3aH-indeno[1,2-d]oxazole
|
|
2757083-53-5
|
|
(3aR,8aS)-2-(6-Methylpyridin-2-yl)-8,8a-dihydro-3aH-indeno[1,2-d]oxazole
|
|
2757082-60-1
|
|
(3aR,8aS)-2-(6-Cyclopropylpyridin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole
|
|
2757082-99-6
|
|
VRK-IN-1
|
|
2828438-59-9
|
|
[RuCl(p-cymene)(N-((1S,2S)-2-amino-1,2-diphenylethyl)-4-(trifluoromethyl)benzenesulfonamide)]
|
|
2378855-09-3
|
|
chloro-[(S,S)-N-trifluoromethanesulfonyl-1,2-diphenylethylenediamine] (p-cymene) ruthenium complex
|
|
2628438-30-0
|
|
BN-104(BNM-1192)
|
|
2628438-26-4
|
|
RAD51-IN-1
|
|
2938995-50-5
|
|
BPI-460372
|
|
2101739-18-6
|
|
(11bS)-2,6-diphenyl-N,N-bis((S)-1-phenylethyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine
|
|
2762619-63-4
|
|
2-(R)-(tert-butylsulfinyl)phenyl]diphenylphosphine
|
|
1186083-69-1
|
|
2-{[1-(methyldioxo-λ6-sulfanyl)-2'-oxo-1',2'-dihydrospiro[azetidine-3,3'-indole]-1'-yl]methyl}-1-(4,4,4-trifluorobutyl)benzo[d]imidazole-5-carbonitrile
|
|
|
|
Phosphine, dicyclohexyl[1-(tricyclohexylphosphoranylidene)ethyl]- (8CI)
|
|
1259059-77-2
|
|
Phosphorane, [1-[bis(1,1-dimethylethyl)phosphino]ethylidene]tricyclohexyl-
|
|
14185-94-5
|
|
Phosphine, tricyclohexyl[(dicyclohexylphosphino)phenylmethylene]-
|
|
2271302-83-9
|
|
Actinonin
|
|
2271302-85-1
|
|
Ezurpimtrostat hydrochloride（GNS561 hydrochloride）
|
|
13434-13-4
|
|
BTX-1188（Sontigidomide）
|
|
1914148-73-4
|
|
Tricyclo[8.2.2.24,7]hexadeca-4,6,10,12,13,15-hexaene-5-carboxaldehyde, stereoisomer
|
|
2560577-69-5
|
|
4(3H)-Quinazolinone, 8-chloro-6-fluoro-2-(4-morpholinyl)-
|
|
37044-38-5
|
|
8-chloro-6-fluoro-2-morpholinoquinazolin-4-yl 4-methylbenzenesulfonate
|
|
2450351-44-5
|
|
Sevasemten
|
|
2450351-45-6
|
|
Ro 67-7476
|
|
2417395-15-2
|
|
Protosappanin A
|
|
298690-60-5
|
|
(R)-5,7-difluorochroman-4-ol
|
|
102036-28-2
|
|
(R)-1-[(S)-2-[BIS(4-METHOXY-3,5-DIMETHYLPHENYL)PHOSPHINO]FERROCENYL}ETHYLDI-TERT
|
|
1270294-05-7
|
|
Elobixibat
|
|
1019853-03-2
|
|
S(R)]-N-[(R)-(3,5-difluorophenyl)(2-(dicyclohexylphosphino) phenyl)methyl]-N,2-dimethyl-2-propanesulfinamide
|
|
439087-18-0
|
|
1,3-bis(2-bromo-4-(2-phenylpropan-2-yl)phenoxy)propane
|
|
|
|
1,3-Dimesitylimidazolidin-2-ylidene
|
|
3051902-04-3
|
|
1,3-Bis(diphenylphosphinomethyl)benzene
|
|
173035-11-5
|
|
(1S,2S)-N1,N2-bis(2-isopropoxyphenyl)-1,2-diphenylethane-1,2-diamine
|
|
89756-88-7
|
|
(1R,2R)-N1,N2-bis(2-methoxyphenyl)-1,2-diphenylethane-1,2-diamine
|
|
1033618-36-8
|
|
(1R,2R)-N1,N2,1,2-tetraphenylethane-1,2-diamine
|
|
35583-32-5
|
|
(1R,2R)-N1,N2-bis(2-isopropoxyphenyl)-1,2-diphenylethane-1,2-diamine
|
|
35583-19-8
|
|
(1R,2R)-N1,N2-bis(2,6-dimethoxyphenyl)-1,2-diphenylethane-1,2-diamine
|
|
|
|
(1R,2R)-N1,N2-bis(2-(methoxymethyl)phenyl)-1,2-diphenylethane-1,2-diamine
|
|
|
|
OICR-8268
|
|
100-33-4
|
|
CVN293
|
|
3000549-26-5
|
|
SEW2871
|
|
2815296-08-1
|
|
AM-9747
|
|
256414-75-2
|
|
PB94
|
|
2691869-82-4
|
|
Tilfrinib
|
|
3032970-74-1
|
|
UNC0224
|
|
1600515-49-8
|
|
CW-3308
|
|
1197196-48-7
|
|
OGT 2115
|
|
3055592-99-6
|
|
JNJ-28583113
|
|
853929-59-6
|
|
AC-73
|
|
2765255-93-2
|
|
Furimazine (PBI 3939)
|
|
775294-71-8
|
|
BI605906
|
|
1374040-24-0
|
|
Barasertib(AZD1152)
|
|
960293-88-3
|
|
Benzamil(Benzylamiloride)
|
|
722543-31-9
|
|
A 83-01 sodium
|
|
2898-76-2
|
|
SB 202190 hydrochloride
|
|
2828431-89-4
|
|
Serotonin (5-Hydroxytryptamine; 5-HT)
|
|
350228-36-3
|
|
BI 882370
|
|
50-67-9
|
|
ATX968
|
|
1392429-79-6
|
|
COH34
|
|
2973395-71-8
|
|
BAY 60-6583
|
|
906439-72-3
|
|
E4741
|
|
910487-58-0
|
|
DBPR728
|
|
2890191-41-8
|
|
NOX-6-18（GPR132-B-160）
|
|
2702965-64-6
|
|
G6PD activator AG1
|
|
898211-21-7
|
|
Jedi2
|
|
421581-52-4
|
|
Bobcat339
|
|
651005-90-2
|
|
4-DAMP
|
|
2280037-51-4
|
|
Adezmapimod hydrochloride
|
|
1952-15-4
|
|
PF-07054894
|
|
869185-85-3
|
|
E4745
|
|
2413693-96-4
|
|
Selenomethionine
|
|
2936625-34-0
|
|
Semustine
|
|
1464-42-2
|
|
Potrasertib(
IMP7068)
|
|
13909-09-6
|
|
Aprocitentan (ACT-132577)
|
|
2226938-19-6
|
|
Flonoltinib（JAK2/FLT3-IN-1）
|
|
1103522-45-7
|
|
MFI8
|
|
2387765-27-5
|
|
FOT1（CN128）hydrochloride
|
|
694488-83-0
|
|
DiI（DiIC18(3)）
|
|
1335282-05-7
|
|
ARV-393
|
|
41085-99-8
|
|
GLP-1R Agonist DMB（GLP-1R agonist 2 ）
|
|
2851885-95-3
|
|
GNE-495
|
|
281209-71-0
|
|
Capzimin
|
|
1449277-10-4
|
|
Osivelotor(GBT-601; GBT-021601)
|
|
2084868-04-0
|
|
Giredestrant(GDC-9545; RG6171)
|
|
2417955-18-9
|
|
(3R)-3-aMino-4-[(3-hexylphenyl)aMino]-4-oxobutyl]-phosphonic acid
|
|
1953133-47-5
|
|
Acoramidishydrochloride(AG10 hydrochloride)
|
|
909725-61-7
|
|
NX-13（Amelenodor）
|
|
2242751-53-5
|
|
7-bromo-3,3-dibutyl-8-methoxy-2,3-dihydrobenzo[b][1,4]thiazepin-4(5H)-one
|
|
2389235-01-0
|
|
[S(R)]-N-[(R)-[2-(Diphenylphosphino)-4,5-dimethoxyphenyl)]-2,2-dimethylpropyl]-N,2-dimethyl-2-propanesulfinamide
|
|
|
|
[S(R)]-N-[(S)-[2-(Diphenylphosphino)-4,5-dimethoxyphenyl)]-2,2-dimethylpropyl]-N,2-dimethyl-2-propanesulfinamide
|
|
|
|
[S(R)]-N-[(S)-[2-(Diphenylphosphino)-4,5-dimethoxyphenyl)]-2,2-dimethylpropyl]-2-methyl-2-propanesulfinamide
|
|
|
|
[S(R)]-N-[(R)-[2-(Diphenylphosphino)-4,5-dimethoxyphenyl)]-2,2-dimethylpropyl]-2-methyl-2-propanesulfinamide
|
|
|
|
(1,2,5,6-η)-1,5-Cyclooctadiene][(2,3,5,6-η)-2,3,5,6-tetramethyl-2,5-cyclohexadiene-1,4-dione]nickel
|
|
131988-19-7
|
|
(2-(di-tert-butylphosphaneyl)-1H-indole-1-carbonyl)dipropylnickel
|
|
40759-64-6
|
|
2-(dicyclohexylphosphaneyl)-1-(phenylsulfonyl)-1H-indole
|
|
1067175-38-5
|
|
(2-(dicyclohexylphosphaneyl)-5-methoxy-1H-indole-1-carbonyl)dipropylnickel
|
|
1067175-46-5
|
|
(2-(diphenylphosphaneyl)-1H-indole-1-carbonyl)dipropylnickel
|
|
2740506-13-0
|
|
(2-(dicyclohexylphosphaneyl)-5-(trifluoromethyl)-1H-indole-1-carbonyl)dipropylnickel
|
|
1067175-34-1
|
|
tert-butyl 2-(dicyclohexylphosphaneyl)-1H-indole-1-carboxylate
|
|
2740506-06-1
|